Skip to content

Clinical trials

Phase 1/2 Head and Neck Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1/2 Country / region: France Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20151
20174
20181
20191
20202
20212
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed5
Terminated4
Active, not recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Genmab2
Alentis Therapeutics AG1
Assistance Publique - Hôpitaux de Paris1
Bolt Biotherapeutics, Inc.1
Centocor, Inc.1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Gilead Sciences1
Hoffmann-La Roche1
Innate Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms20
Lung Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms7
Breast Neoplasms6
Neoplasms6
Neoplasms by Site6
Squamous Cell Carcinoma of Head and Neck5
Bronchial Neoplasms4
Carcinoma, Bronchogenic4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.